Alexey Kopylov
Overview
Explore the profile of Alexey Kopylov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golovin A, Dzarieva F, Rubetskaya K, Shamadykova D, Usachev D, Pavlova G, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940838
The epidermal growth factor receptor (EGFR) is one of the key oncomarkers in glioblastoma (GB) biomedical research. High levels of EGFR expression and mutations have been found in many GB...
2.
Antipova O, Moiseenko V, Dzarieva F, Savchenko E, Pronin I, Pavlova G, et al.
SLAS Discov
. 2024 Dec;
29(8):100199.
PMID: 39643457
No abstract available.
3.
Pavlova S, Fab L, Dzarieva F, Ryabova A, Revishchin A, Panteleev D, et al.
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598347
: High-grade gliomas remain a virtually incurable form of brain cancer. Current therapies are unable to completely eradicate the tumor, and the tumor cells that survive chemotherapy or radiation therapy...
4.
Antipova O, Moiseenko V, Dzarieva F, Savchenko E, Pronin I, Pavlova G, et al.
SLAS Discov
. 2024 Nov;
29(8):100195.
PMID: 39550895
Development of aptatheranostics for glioblastoma (GB) requires investigating aptamer interactions with cells. The paper has described flow cytometry (FC) assessment of direct interactions of fluorescent anti-CD133 aptamers with cells, focusing...
5.
Kolesnikova V, Revishchin A, Fab L, Alekseeva A, Ryabova A, Pronin I, et al.
Front Oncol
. 2024 Jul;
14:1322795.
PMID: 38988707
Current therapy protocols fail to cure high-grade gliomas and prevent recurrence. Therefore, novel approaches need to be developed. A re-programing of glioma cell fate is an alternative attractive way to...
6.
Pavlova S, Fab L, Savchenko E, Ryabova A, Ryzhova M, Revishchin A, et al.
Pharmaceuticals (Basel)
. 2024 Jan;
17(1).
PMID: 38256907
High-grade gliomas are considered an incurable disease. Despite all the various therapy options available, patient survival remains low, and the tumor usually returns. Tumor resistance to conventional therapy and stimulation...
7.
Pavlova G, Kolesnikova V, Samoylenkova N, Drozd S, Revishchin A, Shamadykova D, et al.
Front Oncol
. 2022 May;
12:880740.
PMID: 35586496
Cancer cell reprogramming based on treatment with G-quadruplex, having antiproliferative power, along with small molecules able to develop iPSCs into neurons, could create a novel approach to diminish the chance...
8.
Alieva R, Novikov R, Tashlitsky V, Arutyunyan A, Kopylov A, Zavyalova E
Nucleosides Nucleotides Nucleic Acids
. 2021 Apr;
40(5):559-577.
PMID: 33847237
Aptamers are structured oligonucleotides that specifically bind their targets. Oligonucleotides can be assembled in large nanostructures via intermolecular duplexes or G-quadruplexes. Addition of aptamers can be used to create nanostructures...
9.
Legatova V, Samoylenkova N, Arutyunyan A, Tashlitsky V, Zavyalova E, Usachev D, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33806042
G-quadruplex oligonucleotides (GQs) exhibit specific anti-proliferative activity in human cancer cell lines, and they can selectively inhibit the viability/proliferation of cancer cell lines vs. non-cancer ones. This ability could be...
10.
Ambartsumyan O, Gribanyov D, Kukushkin V, Kopylov A, Zavyalova E
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32397680
Viral infections are among the main causes of morbidity and mortality of humans; sensitive and specific diagnostic methods for the rapid identification of viral pathogens are required. Surface-enhanced Raman spectroscopy...